BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: April 2021

3 posts
Former Lilly CEO Josh Bilenker & Former Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences

Biotech NewsEx-Lilly CEO Josh Bilenker & Ex-Novartis Head of Oncology Jeff Engelman Announce Treeline Biosciences

  • BioTech Health X
  • April 30, 2021
Two powerhouse executives have joined forces to form a brand new cancer Biotech company. Josh Bilenker, M.D., and…
0 Shares
0
0
0
0
0
0
0
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

  • BioTech Health X
  • April 29, 2021
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
0 Shares
0
0
0
0
0
0
0
Welcome To BioTech Health X

Biotech NewsWelcome To BioTech Health X

  • BioTech Health X
  • April 28, 2021
The New Leader in BioTech News, BioTech Stock Information & BioTech Industry Analysis BioTech Health X delivers the…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Aclaris (ACRS) Advances Groundbreaking Therapies for Autoimmune Diseases
  • Pulmonx (LUNG) Reports $68.7M Revenue with 28% Growth and COPD Innovations
  • UroGen (URGN) Posts $25.2M Q3 Revenue, Targets $5B Market with UGN-102 Launch
  • ABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study
  • Rigel (RIGL)’s Q3 2024 Revenue Hits $55.3M
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • November 20, 2024
    Aclaris (ACRS) Advances Groundbreaking Therapies for Autoimmune Diseases
    • November 17, 2024
    Pulmonx (LUNG) Reports $68.7M Revenue with 28% Growth and COPD Innovations
    Genentech Strategic Pivot The Closure of Its Cancer Immunology Unit
    • November 17, 2024
    UroGen (URGN) Posts $25.2M Q3 Revenue, Targets $5B Market with UGN-102 Launch
    • November 14, 2024
    ABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study
    Biogen Expands Immunology Portfolio with Strategic Acquisition
    • November 12, 2024
    Rigel (RIGL)’s Q3 2024 Revenue Hits $55.3M
Recent Posts
  • Lakeside Holding (LSH) Acquires Hupan Pharmaceutical to Enter China’s Medical Logistics Market
    • November 11, 2024
  • Autolus (AUTL) Reports Obe-cel Launch Progress and Strong Cash Position in Q2 2024
    • November 10, 2024
  • Biogen Expands Immunology Portfolio with Strategic Acquisition
    FDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer
    • November 8, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (79)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top